Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Alamar Biosciences, Inc.ALMR · Entity 1791 | Director | April 20, 2026 | April 21, 2026 |
| CERUS CORPCERS · Entity 5431 | Director | June 02, 2026 | June 02, 2026 |
| REVVITY, INC.RVTY · Entity 3382 | Director | May 07, 2026 | May 11, 2026 |
| STANDARD BIOTOOLS INC.LAB · Entity 6116 | Director | June 18, 2026 | June 23, 2026 |
| Telesis Bio Inc.TBIO · Entity 15606 | Director | July 06, 2023 | May 03, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Alamar Biosciences, Inc.
Report date April 20, 2026 · Filed April 21, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.59 · Expires 2031-04-20 | Direct | 0 |
Reported balance
After 2026-04-20 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-04-20 · Other · Disposed 49,627 · Balance 0 F1: Each share of Class B Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the initial public offering of the Issuer's Common Stock. F2: Fully vested. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.59 · Expires 2031-04-20 | Direct | 49,627 |
Reported balance
After 2026-04-20 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-04-20 · Other · Acquired 49,627 · Balance 49,627 F1: Each share of Class B Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the initial public offering of the Issuer's Common Stock. F2: Fully vested. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $3.10 · Expires 2035-04-15 | Direct | 0 |
Reported balance
After 2026-04-20 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-04-20 · Other · Disposed 33,085 · Balance 0 F1: Each share of Class B Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the initial public offering of the Issuer's Common Stock. F3: The shares subject to the option vest in equal monthly installments over 48 months measured from January 1, 2025, subject to the reporting person's continuous service as of each such vesting date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $3.10 · Expires 2035-04-15 | Direct | 33,085 |
Reported balance
After 2026-04-20 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-04-20 · Other · Acquired 33,085 · Balance 33,085 F1: Each share of Class B Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the initial public offering of the Issuer's Common Stock. F3: The shares subject to the option vest in equal monthly installments over 48 months measured from January 1, 2025, subject to the reporting person's continuous service as of each such vesting date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $7.60 · Expires 2036-01-14 | Direct | 0 |
Reported balance
After 2026-04-20 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-04-20 · Other · Disposed 124,069 · Balance 0 F1: Each share of Class B Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the initial public offering of the Issuer's Common Stock. F4: Twenty-five percent of the shares subject to the option vest on January 15, 2027, and 1/48th of the shares vest monthly thereafter, subject to the reporting person's continuous service through each such vesting date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $7.60 · Expires 2036-01-14 | Direct | 124,069 |
Reported balance
After 2026-04-20 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-04-20 · Other · Acquired 124,069 · Balance 124,069 F1: Each share of Class B Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the initial public offering of the Issuer's Common Stock. F4: Twenty-five percent of the shares subject to the option vest on January 15, 2027, and 1/48th of the shares vest monthly thereafter, subject to the reporting person's continuous service through each such vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Each share of Class B Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the initial public offering of the Issuer's Common Stock.
F2: Fully vested.
F3: The shares subject to the option vest in equal monthly installments over 48 months measured from January 1, 2025, subject to the reporting person's continuous service as of each such vesting date.
F4: Twenty-five percent of the shares subject to the option vest on January 15, 2027, and 1/48th of the shares vest monthly thereafter, subject to the reporting person's continuous service through each such vesting date.
CERUS CORP
Report date June 02, 2026 · Filed June 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 340,059 |
Reported balance
After 2026-06-02 transaction · row 1
1 source rowRow 1 · 2026-06-02 · Grant · Acquired 60,000 · Balance 340,059 F1: Represents RSUs granted pursuant to the Issuer's 2024 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vest on the earlier of the first anniversary of the date of grant or the day prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents RSUs granted pursuant to the Issuer's 2024 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vest on the earlier of the first anniversary of the date of grant or the day prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such vesting date.
REVVITY, INC.
Report date May 07, 2026 · Filed May 11, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 23,354 |
Ending reported balance
After 2026-05-07 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-05-07 · Grant · Acquired 1,015 · Balance 22,089 F1: The Reporting Person was granted restricted stock units, with each unit representing a contingent right to receive one share of the issuer's common stock. The grant of restricted stock units will fully vest on April 27, 2027, the scheduled date for the issuer's next annual meeting of shareholders, subject to the Reporting Person's continued service through such date or, if earlier, upon the Reporting Person's death, disability or qualifying retirement, or the termination of the Reporting Person's service within 12 months following a change in control. Row 2 · 2026-05-07 · Grant · Acquired 1,265 · Balance 23,354 |
Filing footnotes · ownership attribution and instrument terms
F1: The Reporting Person was granted restricted stock units, with each unit representing a contingent right to receive one share of the issuer's common stock. The grant of restricted stock units will fully vest on April 27, 2027, the scheduled date for the issuer's next annual meeting of shareholders, subject to the Reporting Person's continued service through such date or, if earlier, upon the Reporting Person's death, disability or qualifying retirement, or the termination of the Reporting Person's service within 12 months following a change in control.
STANDARD BIOTOOLS INC.
Report date June 18, 2026 · Filed June 23, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 309,978 |
Reported balance
After 2026-06-18 transaction · row 1
1 source rowRow 1 · 2026-06-18 · Grant · Acquired 99,116 · Balance 309,978 F1: Represents Restricted Stock Units ("RSUs") that vest in full on the earlier to occur of June 18, 2027 and one day prior to the date of the Company's next annual meeting of stockholders, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the right to receive one share of common stock upon vesting. |
| Stock Option (Right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.83 · Expires 2036-06-18 | Direct | 175,923 |
Reported balance
After 2026-06-18 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-06-18 · Grant · Acquired 175,923 · Balance 175,923 F3: The Option becomes exercisable in twelve equal monthly installments beginning on July 18, 2026, subject to the Reporting Person's continued service through the applicable vesting date. |
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 4,225 |
Reported balance
Holding disclosure · report date 2026-06-18 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 4,225 F2: Shares held indirectly by First Amended and Restated Revocable Trust Agreement for The Franklin R. Witney and Catherine J. Caulfield-Witney Trust Agreement Dated September 25, 2009 (dated July 31, 2018). |
Filing footnotes · ownership attribution and instrument terms
F1: Represents Restricted Stock Units ("RSUs") that vest in full on the earlier to occur of June 18, 2027 and one day prior to the date of the Company's next annual meeting of stockholders, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the right to receive one share of common stock upon vesting.
F2: Shares held indirectly by First Amended and Restated Revocable Trust Agreement for The Franklin R. Witney and Catherine J. Caulfield-Witney Trust Agreement Dated September 25, 2009 (dated July 31, 2018).
F3: The Option becomes exercisable in twelve equal monthly installments beginning on July 18, 2026, subject to the Reporting Person's continued service through the applicable vesting date.
Telesis Bio Inc.
Report date July 06, 2023 · Filed May 03, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 115,736 |
Ending reported balance
After 2024-05-01 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2023-07-06 · Grant · Acquired 46,752 · Balance 67,382 F1: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Issuer's Common Stock for each RSU. Subject to the Reporting Person continuing as a Service Provider (as defined in the Issuer's 2021 Stock Incentive Plan (the "Plan")) through such date, 100% of the RSUs shall vest on the earlier of the one-year anniversary of the date of grant or on the date of the annual meeting of the Issuer's stockholders following the date of grant. Row 2 · 2024-05-01 · Grant · Acquired 48,354 · Balance 115,736 F2: The Reporting Person was granted RSUs, which represent a contingent right to receive one share of Issuer's Common Stock for each RSU. Subject to the Reporting Person continuing as a Service Provider (as defined in the Plan) through each applicable date, 28,113 of the RSUs shall vest on January 1, 2025, and 20,241 of the RSUs shall vest on the earlier of the one-year anniversary of the date of grant or on the date of the annual meeting of the Issuer's stockholders following the date of grant. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.54 · Expires 2033-07-06 | Direct | 70,129 |
Reported balance
After 2023-07-06 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2023-07-06 · Grant · Acquired 70,129 · Balance 70,129 F3: Subject to the Reporting Person continuing as a Service Provider (as defined in the Plan) through such date, 100% of the shares subject to the option shall vest on the earlier of the one-year anniversary of the date of grant or on the date of the annual meeting of the Issuer's stockholders following the date of grant. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.36 · Expires 2034-05-01 | Direct | 30,362 |
Reported balance
After 2024-05-01 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2024-05-01 · Grant · Acquired 30,362 · Balance 30,362 F3: Subject to the Reporting Person continuing as a Service Provider (as defined in the Plan) through such date, 100% of the shares subject to the option shall vest on the earlier of the one-year anniversary of the date of grant or on the date of the annual meeting of the Issuer's stockholders following the date of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Issuer's Common Stock for each RSU. Subject to the Reporting Person continuing as a Service Provider (as defined in the Issuer's 2021 Stock Incentive Plan (the "Plan")) through such date, 100% of the RSUs shall vest on the earlier of the one-year anniversary of the date of grant or on the date of the annual meeting of the Issuer's stockholders following the date of grant.
F2: The Reporting Person was granted RSUs, which represent a contingent right to receive one share of Issuer's Common Stock for each RSU. Subject to the Reporting Person continuing as a Service Provider (as defined in the Plan) through each applicable date, 28,113 of the RSUs shall vest on January 1, 2025, and 20,241 of the RSUs shall vest on the earlier of the one-year anniversary of the date of grant or on the date of the annual meeting of the Issuer's stockholders following the date of grant.
F3: Subject to the Reporting Person continuing as a Service Provider (as defined in the Plan) through such date, 100% of the shares subject to the option shall vest on the earlier of the one-year anniversary of the date of grant or on the date of the annual meeting of the Issuer's stockholders following the date of grant.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 18, 2026 Filed Jun 23, 2026 21:43 UTC | STANDARD BIOTOOLS INC. LAB · Entity 6116 | GrantStock Option (Right to buy) · Derivative | 175,923 | $0.00 Strike: $0.83 | $0.00 |
DisclosureSEC source: 0001193125-26-279830 · ownership.xml · derivative · entry 3 Witney Frank · CIK 0001455312 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 175,923 Underlying: Common Stock · 175,923 shares Expires 2036-06-18 F3 · derivative.exercise_date: The Option becomes exercisable in twelve equal monthly installments beginning on July 18, 2026, subject to the Reporting Person's continued service through the applicable vesting date. Read SEC document |
| June 18, 2026 Filed Jun 23, 2026 21:43 UTC | STANDARD BIOTOOLS INC. LAB · Entity 6116 | GrantCommon Stock | 99,116 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-279830 · ownership.xml · nonDerivative · entry 1 Witney Frank · CIK 0001455312 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 309,978 F1 · shares: Represents Restricted Stock Units ("RSUs") that vest in full on the earlier to occur of June 18, 2027 and one day prior to the date of the Company's next annual meeting of stockholders, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the right to receive one share of common stock upon vesting. Read SEC document |
| June 02, 2026 Filed Jun 2, 2026 23:37 UTC | CERUS CORP CERS · Entity 5431 | GrantCommon Stock | 60,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-254094 · ownership.xml · nonDerivative · entry 1 Witney Frank · CIK 0001455312 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 340,059 F1 · shares: Represents RSUs granted pursuant to the Issuer's 2024 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vest on the earlier of the first anniversary of the date of grant or the day prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such vesting date. Read SEC document |
| May 07, 2026 Filed May 11, 2026 20:05 UTC | REVVITY, INC. RVTY · Entity 3382 | GrantCommon Stock | 1,265 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-216729 · ownership.xml · nonDerivative · entry 2 Witney Frank · CIK 0001455312 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,354 Read SEC document |
| May 07, 2026 Filed May 11, 2026 20:05 UTC | REVVITY, INC. RVTY · Entity 3382 | GrantCommon Stock | 1,015 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-216729 · ownership.xml · nonDerivative · entry 1 Witney Frank · CIK 0001455312 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,089 F1 · shares: The Reporting Person was granted restricted stock units, with each unit representing a contingent right to receive one share of the issuer's common stock. The grant of restricted stock units will fully vest on April 27, 2027, the scheduled date for the issuer's next annual meeting of shareholders, subject to the Reporting Person's continued service through such date or, if earlier, upon the Reporting Person's death, disability or qualifying retirement, or the termination of the Reporting Person's service within 12 months following a change in control. Read SEC document |
| April 20, 2026 Filed Apr 21, 2026 00:37 UTC | Alamar Biosciences, Inc. ALMR · Entity 1791 | OtherStock Option (Right to Buy) · Derivative | 124,069 | $0.00 Strike: $7.60 | $0.00 |
DisclosureSEC source: 0001455312-26-000004 · form4-04212026_120458.xml · derivative · entry 6 Witney Frank · CIK 0001455312 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 124,069 Underlying: Common Stock · 124,069 shares Expires 2036-01-14 F1 · kind: Each share of Class B Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the initial public offering of the Issuer's Common Stock. F4 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vest on January 15, 2027, and 1/48th of the shares vest monthly thereafter, subject to the reporting person's continuous service through each such vesting date. Read SEC document |
| April 20, 2026 Filed Apr 21, 2026 00:37 UTC | Alamar Biosciences, Inc. ALMR · Entity 1791 | OtherStock Option (Right to Buy) · Derivative | 124,069 | $0.00 Strike: $7.60 | $0.00 |
DisclosureSEC source: 0001455312-26-000004 · form4-04212026_120458.xml · derivative · entry 5 Witney Frank · CIK 0001455312 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class B Common Stock · 124,069 shares Expires 2036-01-14 F1 · kind: Each share of Class B Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the initial public offering of the Issuer's Common Stock. F4 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vest on January 15, 2027, and 1/48th of the shares vest monthly thereafter, subject to the reporting person's continuous service through each such vesting date. Read SEC document |
| April 20, 2026 Filed Apr 21, 2026 00:37 UTC | Alamar Biosciences, Inc. ALMR · Entity 1791 | OtherStock Option (Right to Buy) · Derivative | 33,085 | $0.00 Strike: $3.10 | $0.00 |
DisclosureSEC source: 0001455312-26-000004 · form4-04212026_120458.xml · derivative · entry 4 Witney Frank · CIK 0001455312 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,085 Underlying: Common Stock · 33,085 shares Expires 2035-04-15 F1 · kind: Each share of Class B Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the initial public offering of the Issuer's Common Stock. F3 · derivative.exercise_date: The shares subject to the option vest in equal monthly installments over 48 months measured from January 1, 2025, subject to the reporting person's continuous service as of each such vesting date. Read SEC document |
| April 20, 2026 Filed Apr 21, 2026 00:37 UTC | Alamar Biosciences, Inc. ALMR · Entity 1791 | OtherStock Option (Right to Buy) · Derivative | 33,085 | $0.00 Strike: $3.10 | $0.00 |
DisclosureSEC source: 0001455312-26-000004 · form4-04212026_120458.xml · derivative · entry 3 Witney Frank · CIK 0001455312 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class B Common Stock · 33,085 shares Expires 2035-04-15 F1 · kind: Each share of Class B Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the initial public offering of the Issuer's Common Stock. F3 · derivative.exercise_date: The shares subject to the option vest in equal monthly installments over 48 months measured from January 1, 2025, subject to the reporting person's continuous service as of each such vesting date. Read SEC document |
| April 20, 2026 Filed Apr 21, 2026 00:37 UTC | Alamar Biosciences, Inc. ALMR · Entity 1791 | OtherStock Option (Right to Buy) · Derivative | 49,627 | $0.00 Strike: $0.59 | $0.00 |
DisclosureSEC source: 0001455312-26-000004 · form4-04212026_120458.xml · derivative · entry 2 Witney Frank · CIK 0001455312 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,627 Underlying: Common Stock · 49,627 shares Expires 2031-04-20 F1 · kind: Each share of Class B Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the initial public offering of the Issuer's Common Stock. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| April 20, 2026 Filed Apr 21, 2026 00:37 UTC | Alamar Biosciences, Inc. ALMR · Entity 1791 | OtherStock Option (Right to Buy) · Derivative | 49,627 | $0.00 Strike: $0.59 | $0.00 |
DisclosureSEC source: 0001455312-26-000004 · form4-04212026_120458.xml · derivative · entry 1 Witney Frank · CIK 0001455312 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class B Common Stock · 49,627 shares Expires 2031-04-20 F1 · kind: Each share of Class B Common Stock was reclassified into one share of Common Stock immediately prior to the completion of the initial public offering of the Issuer's Common Stock. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| June 20, 2025 Filed Jun 24, 2025 22:53 UTC | STANDARD BIOTOOLS INC. LAB · Entity 6116 | GrantStock Option (Right to buy) · Derivative | 125,660 | $0.00 Strike: $1.05 | $0.00 |
DisclosureSEC source: 0000950170-25-089641 · ownership.xml · derivative · entry 3 Witney Frank · CIK 0001455312 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 125,660 Underlying: Common Stock · 125,660 shares Expires 2035-06-20 F3 · derivative.exercise_date: The Option becomes exercisable in twelve equal monthly installments beginning on July 20, 2025, subject to the Reporting Person's continued service through the applicable vesting date. Read SEC document |
| June 20, 2025 Filed Jun 24, 2025 22:53 UTC | STANDARD BIOTOOLS INC. LAB · Entity 6116 | GrantCommon Stock | 94,592 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-089641 · ownership.xml · nonDerivative · entry 1 Witney Frank · CIK 0001455312 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 210,862 F1 · shares: Represents Restricted Stock Units ("RSUs") that vest in full on the earlier to occur of June 20, 2026 and one day prior to the date of the Company's next annual meeting of stockholders, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the right to receive one share of common stock upon vesting. Read SEC document |
| June 03, 2025 Filed Jun 4, 2025 22:53 UTC | CERUS CORP CERS · Entity 5431 | GrantCommon Stock | 60,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-081869 · ownership.xml · nonDerivative · entry 1 Witney Frank · CIK 0001455312 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 280,059 F1 · shares: Represents RSUs granted pursuant to the Issuer's 2024 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vest on the earlier of the first anniversary of the date of grant or the day prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such vesting date. Read SEC document |
| April 30, 2025 Filed May 1, 2025 20:05 UTC | REVVITY, INC. RVTY · Entity 3382 | GrantCommon Stock | 1,338 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-061821 · ownership.xml · nonDerivative · entry 2 Witney Frank · CIK 0001455312 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,074 Read SEC document |
| April 30, 2025 Filed May 1, 2025 20:05 UTC | REVVITY, INC. RVTY · Entity 3382 | GrantCommon Stock | 1,074 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-061821 · ownership.xml · nonDerivative · entry 1 Witney Frank · CIK 0001455312 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,736 F1 · shares: The Reporting Person was granted restricted stock units, with each unit representing a contingent right to receive one share of the issuer's common stock. The grant of restricted stock units will fully vest on April 28, 2026, the scheduled date for the issuer's next annual meeting of shareholders, subject to the Reporting Person's continued service through such date or, if earlier, upon the Reporting Person's death, disability or qualifying retirement, or the termination of the Reporting Person's service within 12 months following a change in control. Read SEC document |
| June 28, 2024 Filed Jul 2, 2024 21:30 UTC | STANDARD BIOTOOLS INC. LAB · Entity 6116 | GrantStock Option (Right to buy) · Derivative | 72,213 | $0.00 Strike: $1.77 | $0.00 |
DisclosureSEC source: 0000950170-24-080785 · ownership.xml · derivative · entry 3 Witney Frank · CIK 0001455312 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 72,213 Underlying: Common Stock · 72,213 shares Expires 2034-06-28 F3 · derivative.exercise_date: The Option becomes exercisable in twelve equal monthly installments beginning on July 28, 2024, subject to the Reporting Person's continued service through the applicable vesting date. Read SEC document |
| June 28, 2024 Filed Jul 2, 2024 21:30 UTC | STANDARD BIOTOOLS INC. LAB · Entity 6116 | GrantCommon Stock | 43,128 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-080785 · ownership.xml · nonDerivative · entry 1 Witney Frank · CIK 0001455312 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 116,270 F1 · shares: Represents Restricted Stock Units ("RSUs") that vest in full on the earlier to occur of June 28, 2025 and one day prior to the date of the Company's next annual meeting of stockholders, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the right to receive one share of common stock upon vesting. Read SEC document |
| June 05, 2024 Filed Jun 7, 2024 00:03 UTC | CERUS CORP CERS · Entity 5431 | GrantCommon Stock | 40,000 | $5.00 | $200,000.00 |
DisclosureSEC source: 0001209191-24-005827 · doc4.xml · nonDerivative · entry 1 Witney Frank · CIK 0001455312 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 220,059 F1 · shares: Represents the number of shares underlying RSUs. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vest on the earlier of the first anniversary of the date of grant or the day prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such vesting date. Read SEC document |
| May 09, 2024 Filed May 11, 2024 00:17 UTC | CERUS CORP CERS · Entity 5431 | PurchaseCommon Stock | 20,000 | $1.89 | $37,800.00 |
DisclosureSEC source: 0001209191-24-005610 · doc4.xml · nonDerivative · entry 1 Witney Frank · CIK 0001455312 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 180,059 Read SEC document |
| May 01, 2024 Filed May 2, 2024 20:05 UTC | REVVITY, INC. RVTY · Entity 3382 | GrantCommon Stock | 1,218 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-052068 · ownership.xml · nonDerivative · entry 2 Witney Frank · CIK 0001455312 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,662 Read SEC document |
| May 01, 2024 Filed May 2, 2024 20:05 UTC | REVVITY, INC. RVTY · Entity 3382 | GrantCommon Stock | 977 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-052068 · ownership.xml · nonDerivative · entry 1 Witney Frank · CIK 0001455312 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,444 F1 · shares: The Reporting Person was granted restricted stock units, with each unit representing a contingent right to receive one share of the issuer's common stock. The grant of restricted stock units will fully vest on April 22, 2025, the scheduled date for the issuer's next annual meeting of shareholders, subject to the reporting person's continued service through such date or, if earlier, upon the reporting person's death, disability or qualifying retirement, or the termination of the reporting person's service within 12 months following a change in control. Read SEC document |
| May 01, 2024 Filed May 3, 2024 19:14 UTC | Telesis Bio Inc. TBIO · Entity 15606 | GrantStock Option (right to buy) · Derivative | 30,362 | $0.00 Strike: $0.36 | $0.00 |
DisclosureSEC source: 0000950170-24-053136 · ownership.xml · derivative · entry 4 Witney Frank · CIK 0001455312 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,362 Underlying: Common Stock · 30,362 shares Expires 2034-05-01 F3 · derivative.exercise_date: Subject to the Reporting Person continuing as a Service Provider (as defined in the Plan) through such date, 100% of the shares subject to the option shall vest on the earlier of the one-year anniversary of the date of grant or on the date of the annual meeting of the Issuer's stockholders following the date of grant. Read SEC document |
| May 01, 2024 Filed May 3, 2024 19:14 UTC | Telesis Bio Inc. TBIO · Entity 15606 | GrantCommon Stock | 48,354 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-053136 · ownership.xml · nonDerivative · entry 2 Witney Frank · CIK 0001455312 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 115,736 F2 · shares: The Reporting Person was granted RSUs, which represent a contingent right to receive one share of Issuer's Common Stock for each RSU. Subject to the Reporting Person continuing as a Service Provider (as defined in the Plan) through each applicable date, 28,113 of the RSUs shall vest on January 1, 2025, and 20,241 of the RSUs shall vest on the earlier of the one-year anniversary of the date of grant or on the date of the annual meeting of the Issuer's stockholders following the date of grant. Read SEC document |
| July 06, 2023 Filed May 3, 2024 19:14 UTC | Telesis Bio Inc. TBIO · Entity 15606 | GrantStock Option (right to buy) · Derivative | 70,129 | $0.00 Strike: $1.54 | $0.00 |
DisclosureSEC source: 0000950170-24-053136 · ownership.xml · derivative · entry 3 Witney Frank · CIK 0001455312 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,129 Underlying: Common Stock · 70,129 shares Expires 2033-07-06 F3 · derivative.exercise_date: Subject to the Reporting Person continuing as a Service Provider (as defined in the Plan) through such date, 100% of the shares subject to the option shall vest on the earlier of the one-year anniversary of the date of grant or on the date of the annual meeting of the Issuer's stockholders following the date of grant. Read SEC document |
| July 06, 2023 Filed May 3, 2024 19:14 UTC | Telesis Bio Inc. TBIO · Entity 15606 | GrantCommon Stock | 46,752 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-053136 · ownership.xml · nonDerivative · entry 1 Witney Frank · CIK 0001455312 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,382 F1 · shares: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Issuer's Common Stock for each RSU. Subject to the Reporting Person continuing as a Service Provider (as defined in the Issuer's 2021 Stock Incentive Plan (the "Plan")) through such date, 100% of the RSUs shall vest on the earlier of the one-year anniversary of the date of grant or on the date of the annual meeting of the Issuer's stockholders following the date of grant. Read SEC document |
| June 14, 2023 Filed Jun 17, 2023 00:46 UTC | STANDARD BIOTOOLS INC. LAB · Entity 6116 | GrantStock Option (Right to Buy) · Derivative | 35,380 | $0.00 Strike: $2.18 | $0.00 |
DisclosureSEC source: 0001162194-23-000046 · wk-form4_1686962794.xml · derivative · entry 3 Witney Frank · CIK 0001455312 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,380 Underlying: Common Stock · 35,380 shares Expires 2033-06-14 F3 · derivative.exercise_date: The Option becomes exercisable in twelve equal monthly increments beginning on July 14, 2023 subject to the Reporting Person's continued service through the applicable vesting date. Read SEC document |
| June 14, 2023 Filed Jun 17, 2023 00:46 UTC | STANDARD BIOTOOLS INC. LAB · Entity 6116 | GrantCommon Stock | 26,376 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-23-000046 · wk-form4_1686962794.xml · nonDerivative · entry 1 Witney Frank · CIK 0001455312 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,142 F1 · shares: Consists of Restricted Stock Units. Each Restricted Stock Unit represents the right to receive one share of common stock upon vesting. The Restricted Stock Units vest in full on the earlier to occur of June 14, 2024 and one day prior to the date of the Company's next annual meeting of stockholders subject to the Reporting Person's continued service through the applicable vesting date. Read SEC document |
| June 07, 2023 Filed Jun 9, 2023 20:17 UTC | CERUS CORP CERS · Entity 5431 | GrantCommon Stock | 40,000 | $5.00 | $200,000.00 |
DisclosureSEC source: 0001209191-23-035806 · doc4.xml · nonDerivative · entry 1 Witney Frank · CIK 0001455312 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 160,059 F1 · shares: Represents the number of shares underlying RSUs. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vest on the earlier of the first anniversary of the date of grant or the day prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such vesting date. Read SEC document |
| May 15, 2023 Filed May 17, 2023 20:06 UTC | REVVITY, INC. RVTY · Entity 3382 | GrantCommon Stock | 955 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-23-022717 · ownership.xml · nonDerivative · entry 2 Witney Frank · CIK 0001455312 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,467 Read SEC document |
| May 15, 2023 Filed May 17, 2023 20:06 UTC | REVVITY, INC. RVTY · Entity 3382 | GrantCommon Stock | 783 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-23-022717 · ownership.xml · nonDerivative · entry 1 Witney Frank · CIK 0001455312 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,512 F1 · shares: The reporting person was granted restricted stock units, with each unit representing a contingent right to receive one share of the issuer's common stock. The grant of restricted stock units will fully vest on April 23, 2024, the scheduled date for the issuer's next annual meeting of shareholders, subject to the reporting person's continued service through such date or, if earlier, upon the reporting person's death, disability or qualifying retirement, or the termination of the reporting person's service within 12 months following a change in control. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 22:05 UTC | STANDARD BIOTOOLS INC. LAB · Entity 6116 | GrantStock Option (Right to Buy) · Derivative | 42,571 | $0.00 Strike: $1.86 | $0.00 |
DisclosureSEC source: 0001162194-22-000078 · wf-form4_165550351788011.xml · derivative · entry 2 Witney Frank · CIK 0001455312 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,571 Underlying: Common Stock · 42,571 shares Expires 2032-06-15 F2 · derivative.exercise_date: The Option becomes exercisable in twelve equal monthly increments beginning on July 15, 2022. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 22:05 UTC | STANDARD BIOTOOLS INC. LAB · Entity 6116 | GrantCommon Stock | 30,914 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-22-000078 · wf-form4_165550351788011.xml · nonDerivative · entry 1 Witney Frank · CIK 0001455312 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,766 F1 · shares: Represents Restricted Stock Units that vest in full on the earlier to occur of June 15, 2023 and one day prior to the date of the Issuer's next annual meeting of stockholders. Read SEC document |
| June 09, 2022 Filed Jun 13, 2022 18:10 UTC | Telesis Bio Inc. DNAY · Entity 15606 | GrantStock Option (right to buy) · Derivative | 30,945 | $0.00 Strike: $3.49 | $0.00 |
DisclosureSEC source: 0001850079-22-000050 · wf-form4_165515818891627.xml · derivative · entry 2 Witney Frank · CIK 0001455312 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,945 Underlying: Common Stock · 30,945 shares Expires 2032-06-09 F2 · derivative.exercise_date: Subject to the Reporting Person's continuing as a Service Provider (as defined in the Issuer's 2021 Sock Incentive Plan) through each such date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one-year anniversary of the Grant Date or (ii) the day prior to the date of the annual meeting of the Issuer's shareholders next following the Grant Date. "Grant Date" shall mean June 9, 2022. Read SEC document |
| June 09, 2022 Filed Jun 13, 2022 18:10 UTC | Telesis Bio Inc. DNAY · Entity 15606 | GrantCommon Stock | 20,630 | $0.00 | $0.00 |
DisclosureSEC source: 0001850079-22-000050 · wf-form4_165515818891627.xml · nonDerivative · entry 1 Witney Frank · CIK 0001455312 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,630 F1 · shares: These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Codex DNA, Inc.'s (the "Issuer") Common Stock. Subject to the Reporting Person's continuing as a Service Provider (as defined in the Issuer's 2021 Sock Incentive Plan) through each such date, one hundred percent (100%) of the RSUs shall vest on the earlier of (i) the one-year anniversary of the Grant Date or (ii) the day prior to the date of the annual meeting of the Issuer's shareholders next following the Grant Date. "Grant Date" shall mean June 9, 2022. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 21:22 UTC | CERUS CORP CERS · Entity 5431 | GrantOption (Right to Buy) · Derivative | 39,866 | Not disclosed Strike: $4.84 | Not disclosed |
DisclosureSEC source: 0001209191-22-034214 · doc4.xml · derivative · entry 2 Witney Frank · CIK 0001455312 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,866 Underlying: Common Stock · 39,866 shares Expires 2032-05-31 F3 · price: Not applicable. F2 · derivative.exercise_date: The option shall vest one year from the date of grant. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 21:22 UTC | CERUS CORP CERS · Entity 5431 | GrantCommon Stock | 20,454 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-034214 · doc4.xml · nonDerivative · entry 1 Witney Frank · CIK 0001455312 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,059 F1 · shares: Represents the number of shares underlying RSUs. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vest on the earlier of the first anniversary of the date of grant or the day prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such vesting date. Read SEC document |
| May 06, 2022 Filed May 9, 2022 20:05 UTC | REVVITY, INC. PKI · Entity 3382 | GrantCommon Stock | 744 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-017246 · doc4.xml · nonDerivative · entry 2 Witney Frank · CIK 0001455312 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,729 Read SEC document |
| May 06, 2022 Filed May 9, 2022 20:05 UTC | REVVITY, INC. PKI · Entity 3382 | GrantCommon Stock | 610 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-017246 · doc4.xml · nonDerivative · entry 1 Witney Frank · CIK 0001455312 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,985 F1 · shares: The reporting person was granted restricted stock units, with each unit representing a contingent right to receive one share of the issuer's common stock. The grant of restricted stock units will fully vest on April 25, 2023, the scheduled date for the issuer's next annual meeting of shareholders, subject to the reporting person's continued service through such date or, if earlier, upon the reporting person's death, disability or qualifying retirement, or the termination of the reporting person's service within 12 months following a change in control. Read SEC document |
| April 04, 2022 Filed Apr 6, 2022 22:35 UTC | STANDARD BIOTOOLS INC. LAB · Entity 6116 | GrantStock Option (Right to Buy) · Derivative | 23,401 | $0.00 Strike: $3.99 | $0.00 |
DisclosureSEC source: 0001162194-22-000043 · wf-form4_164928451242882.xml · derivative · entry 3 Witney Frank · CIK 0001455312 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,401 Underlying: Common Stock · 23,401 shares Expires 2032-04-04 F3 · derivative.exercise_date: The Option becomes exercisable in four equal annual installments beginning on April 4, 2023. Read SEC document |
| April 04, 2022 Filed Apr 6, 2022 22:35 UTC | STANDARD BIOTOOLS INC. LAB · Entity 6116 | GrantCommon Stock | 15,852 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-22-000043 · wf-form4_164928451242882.xml · nonDerivative · entry 1 Witney Frank · CIK 0001455312 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,852 F1 · shares: Represents Restricted Stock Units that vest in four equal annual installments beginning April 4, 2023. Read SEC document |
| June 02, 2021 Filed Jun 4, 2021 00:06 UTC | CERUS CORP CERS · Entity 5431 | GrantOption (Right to Buy) · Derivative | 29,983 | Not disclosed Strike: $5.62 | Not disclosed |
DisclosureSEC source: 0001209191-21-037977 · doc4.xml · derivative · entry 4 Witney Frank · CIK 0001455312 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,983 Underlying: Common Stock · 29,983 shares Expires 2031-06-01 F4 · price: Not applicable. F5 · derivative.exercise_date: The option shall vest on the earlier of (a) one year from the date of grant, or (b) the day prior to the 2022 Annual Meeting of Stockholders. Read SEC document |
| June 02, 2021 Filed Jun 4, 2021 00:06 UTC | CERUS CORP CERS · Entity 5431 | GrantCommon Stock | 14,888 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-037977 · doc4.xml · nonDerivative · entry 2 Witney Frank · CIK 0001455312 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,605 F2 · shares: Represents the number of shares underlying RSUs. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vest on the earlier of the first anniversary of the date of grant or the day prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such vesting date. Read SEC document |
| June 01, 2021 Filed Jun 4, 2021 00:06 UTC | CERUS CORP CERS · Entity 5431 | Exercise / conversionRestricted Stock Unit · Derivative | 13,228 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-037977 · doc4.xml · derivative · entry 3 Witney Frank · CIK 0001455312 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,228 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of Cerus Common Stock. F4 · price: Not applicable. F3 · derivative.exercise_date: This RSU vested one year from the date of grant. F3 · derivative.expiration_date: This RSU vested one year from the date of grant. Read SEC document |
| June 01, 2021 Filed Jun 4, 2021 00:06 UTC | CERUS CORP CERS · Entity 5431 | Exercise / conversionCommon Stock | 13,228 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-037977 · doc4.xml · nonDerivative · entry 1 Witney Frank · CIK 0001455312 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,717 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of Cerus Common Stock. Read SEC document |
| May 07, 2021 Filed May 10, 2021 21:12 UTC | REVVITY, INC. PKI · Entity 3382 | GrantCommon Stock | 709 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-018980 · doc4.xml · nonDerivative · entry 2 Witney Frank · CIK 0001455312 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,375 Read SEC document |
| May 07, 2021 Filed May 10, 2021 21:12 UTC | REVVITY, INC. PKI · Entity 3382 | GrantCommon Stock | 604 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-018980 · doc4.xml · nonDerivative · entry 1 Witney Frank · CIK 0001455312 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,666 F1 · shares: The reporting person was granted restricted stock units, with each unit representing a contingent right to receive one share of the issuer's common stock. The grant of restricted stock units will fully vest on April 26, 2022, the scheduled date for the issuer's next annual meeting of shareholders, subject to the reporting person's continued service through such date or, if earlier, upon the reporting person's death, disability or qualifying retirement, or the termination of the reporting person's service within 12 months following a change in control. Read SEC document |
| June 05, 2020 Filed Jun 10, 2020 00:00 UTC | CERUS CORP CERS · Entity 5431 | Exercise / conversionRestricted Stock Unit · Derivative | 11,184 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-035414 · doc4.xml · derivative · entry 2 Witney Frank · CIK 0001455312 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,184 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F3 · price: Not applicable. F2 · derivative.exercise_date: This restricted stock unit vested one year from the date of grant. F2 · derivative.expiration_date: This restricted stock unit vested one year from the date of grant. Read SEC document |
| June 05, 2020 Filed Jun 10, 2020 00:00 UTC | CERUS CORP CERS · Entity 5431 | Exercise / conversionCommon Stock | 11,184 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-035414 · doc4.xml · nonDerivative · entry 1 Witney Frank · CIK 0001455312 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,489 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. Read SEC document |
| June 03, 2020 Filed Jun 5, 2020 23:03 UTC | CERUS CORP CERS · Entity 5431 | GrantRestricted Stock Unit · Derivative | 13,228 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-034846 · doc4.xml · derivative · entry 2 Witney Frank · CIK 0001455312 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,228 Underlying: Common Stock · 13,228 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock. F2 · price: Not applicable. F4 · derivative.exercise_date: The Restricted Stock Unit shall vest on the earlier of (a) one year from the date of grant, or (b) the day prior to the 2021 Annual Meeting of Stockholders. F4 · derivative.expiration_date: The Restricted Stock Unit shall vest on the earlier of (a) one year from the date of grant, or (b) the day prior to the 2021 Annual Meeting of Stockholders. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.